Transcription	B-protein
factor	I-protein
NF-kappa	I-protein
B	I-protein
regulates	O
Ig	B-protein
lambda	I-protein
light	O
chain	O
gene	O
rearrangement	O
.	O

The	O
tissue-	O
and	O
stage-specific	O
assembly	O
of	O
Ig	B-DNA
and	I-DNA
TCR	I-DNA
genes	I-DNA
is	O
mediated	O
by	O
a	O
common	O
V	B-protein
(	I-protein
D	I-protein
)	I-protein
J	I-protein
recombinase	I-protein
complex	I-protein
in	O
precursor	B-cell_type
lymphocytes	I-cell_type
.	O

Directed	O
alterations	O
in	O
the	O
accessibility	O
of	O
V	B-DNA
,	I-DNA
D	I-DNA
,	I-DNA
and	I-DNA
J	I-DNA
gene	I-DNA
segments	I-DNA
target	O
the	O
recombinase	B-protein
to	O
specific	O
Ag	B-DNA
receptor	I-DNA
loci	I-DNA
.	O

Accessibility	O
within	O
a	O
given	O
locus	B-DNA
is	O
regulated	O
by	O
the	O
functional	O
interaction	O
of	O
transcription	B-protein
factors	I-protein
with	O
cognate	B-DNA
enhancer	I-DNA
elements	I-DNA
and	O
correlates	O
with	O
the	O
transcriptional	O
activity	O
of	O
unrearranged	O
gene	B-DNA
segments	I-DNA
.	O

As	O
demonstrated	O
in	O
our	O
prior	O
studies	O
,	O
rearrangement	O
of	O
the	O
Igkappa	B-DNA
locus	I-DNA
is	O
regulated	O
by	O
the	O
inducible	B-protein
transcription	I-protein
factor	I-protein
NF-kappaB	B-protein
.	O

In	O
contrast	O
to	O
the	O
Igkappa	B-DNA
locus	I-DNA
,	O
known	O
transcriptional	B-DNA
control	I-DNA
elements	I-DNA
in	O
the	O
Iglambda	B-DNA
locus	I-DNA
lack	O
functional	O
NF-kappaB	B-DNA
binding	I-DNA
sites	I-DNA
.	O

Consistent	O
with	O
this	O
observation	O
,	O
the	O
expression	O
of	O
assembled	O
Iglambda	B-DNA
genes	I-DNA
in	O
mature	B-cell_type
B	I-cell_type
cells	I-cell_type
has	O
been	O
shown	O
to	O
be	O
NF-kappaB	B-protein
independent	O
.	O

Nonetheless	O
,	O
we	O
now	O
show	O
that	O
specific	O
repression	O
of	O
NF-kappaB	B-protein
inhibits	O
germline	O
transcription	O
and	O
recombination	O
of	O
Iglambda	B-DNA
gene	I-DNA
segments	I-DNA
in	O
precursor	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

Molecular	O
analyses	O
indicate	O
that	O
the	O
block	O
in	O
NF-kappaB	B-protein
impairs	O
Iglambda	O
rearrangement	O
at	O
the	O
level	O
of	O
recombinase	B-protein
accessibility	O
.	O

In	O
contrast	O
,	O
the	O
activities	O
of	O
known	O
Iglambda	B-DNA
promoter	I-DNA
and	O
enhancer	B-DNA
elements	I-DNA
are	O
unaffected	O
in	O
the	O
same	O
cellular	O
background	O
.	O

These	O
findings	O
expand	O
the	O
range	O
of	O
NF-kappaB	B-protein
action	O
in	O
precursor	B-cell_type
B	I-cell_type
cells	I-cell_type
beyond	O
Igkappa	B-protein
to	O
include	O
the	O
control	O
of	O
recombinational	O
accessibility	O
at	O
both	O
L	B-DNA
chain	I-DNA
loci	I-DNA
.	O

Moreover	O
,	O
our	O
results	O
strongly	O
suggest	O
the	O
existence	O
of	O
a	O
novel	O
Iglambda	B-DNA
regulatory	I-DNA
element	I-DNA
that	O
is	O
either	O
directly	O
or	O
indirectly	O
activated	O
by	O
NF-kappaB	B-protein
during	O
the	O
early	O
stages	O
of	O
B	O
cell	O
development	O
.	O

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
I	NULL
.	NULL

:	NULL
CURIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
Accelerating	NULL
Life	NULL
Sciences	NULL
Sa	NULL
meJournal	NULL
f	NULL
Transcription	NULL
Factor	NULL
NF-	NULL
<	NULL
B	NULL
Regulates	NULL
IgA	NULL
--	NULL
--	NULL
f'Immun010	NULL
gy	NULL
Light	NULL
Chain	NULL
Gene	NULL
Rearrangement	NULL
Heather	NULL
H.	NULL
Bendall	NULL
,	NULL
Michael	NULL
L.	NULL
Sikes	NULL
and	NULL
Eugene	NULL
M.	NULL
Oltz	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
__	NULL
J	NULL
Jpmunol	NULL
2001	NULL
;	NULL
167:264-269	NULL
;	NULL
;	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019.	NULL
doi	NULL
:	NULL
10.4049/jimmunol.167.1.264	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/167/1/264	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
27	NULL
articles	NULL
,	NULL
13	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/167/1/264	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Transcription	NULL
Factor	NULL
NF-B	NULL
Regulates	NULL
IgA	NULL
Light	NULL
Chain	NULL
Gene	NULL
Rearrangement	NULL
'	NULL
Heather	NULL
H.	NULL
Bendall	NULL
,	NULL
Michael	NULL
L.	NULL
Sikes	NULL
,	NULL
and	NULL
Eugene	NULL
M.	NULL
Oltz	NULL
``	NULL
The	NULL
tissue-	NULL
and	NULL
stage-specific	NULL
assembly	NULL
of	NULL
Ig	NULL
and	NULL
TCR	NULL
genes	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
common	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombinase	NULL
complex	NULL
in	NULL
precursor	NULL
lymphocytes	NULL
.	NULL

Directed	NULL
alterations	NULL
in	NULL
the	NULL
accessibility	NULL
of	NULL
V	NULL
,	NULL
D	NULL
,	NULL
and	NULL
J	NULL
gene	NULL
segments	NULL
target	NULL
the	NULL
recombinase	NULL
to	NULL
specific	NULL
Ag	NULL
receptor	NULL
loci	NULL
.	NULL

Accessibility	NULL
within	NULL
a	NULL
given	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
functional	NULL
interaction	NULL
of	NULL
transcription	NULL
factors	NULL
with	NULL
cognate	NULL
enhancer	NULL
elements	NULL
and	NULL
correlates	NULL
with	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
unrearranged	NULL
gene	NULL
segments	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
our	NULL
prior	NULL
studies	NULL
,	NULL
rearrangement	NULL
of	NULL
the	NULL
Ig	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
Ig	NULL
locus	NULL
,	NULL
known	NULL
transcriptional	NULL
control	NULL
elements	NULL
in	NULL
the	NULL
IgA	NULL
locus	NULL
lack	NULL
functional	NULL
NF-KB	NULL
binding	NULL
sites	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
assembled	NULL
IgA	NULL
genes	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
NF-rB	NULL
independent	NULL
.	NULL

Nonetheless	NULL
,	NULL
we	NULL
now	NULL
show	NULL
that	NULL
specific	NULL
repression	NULL
of	NULL
NF-B	NULL
inhibits	NULL
germline	NULL
transcription	NULL
and	NULL
recombination	NULL
of	NULL
IgA	NULL
gene	NULL
segments	NULL
in	NULL
precursor	NULL
B	NULL
cells	NULL
.	NULL

Molecular	NULL
analyses	NULL
indicate	NULL
that	NULL
the	NULL
block	NULL
in	NULL
NF-xB	NULL
impairs	NULL
IgA	NULL
rearrangement	NULL
at	NULL
the	NULL
level	NULL
of	NULL
recombinase	NULL
accessibility	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activities	NULL
of	NULL
known	NULL
IgA	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
are	NULL
unaffected	NULL
in	NULL
the	NULL
same	NULL
cellular	NULL
background	NULL
.	NULL

These	NULL
findings	NULL
expand	NULL
the	NULL
range	NULL
of	NULL
NF-KB	NULL
action	NULL
in	NULL
precursor	NULL
B	NULL
cells	NULL
beyond	NULL
Igx	NULL
to	NULL
include	NULL
the	NULL
control	NULL
of	NULL
recombinational	NULL
accessibility	NULL
at	NULL
both	NULL
L	NULL
chain	NULL
loci	NULL
.	NULL

Moreover	NULL
,	NULL
our	NULL
results	NULL
strongly	NULL
suggest	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
novel	NULL
IgA	NULL
regulatory	NULL
element	NULL
that	NULL
is	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
activated	NULL
by	NULL
NF-B	NULL
during	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
167	NULL
:	NULL
264-269.	NULL
genes	NULL
via	NULL
a	NULL
program	NULL
of	NULL
DNA	NULL
recombination	NULL
involving	NULL
large	NULL
arrays	NULL
of	NULL
V	NULL
,	NULL
D	NULL
,	NULL
and	NULL
J	NULL
gene	NULL
segments	NULL
.	NULL

The	NULL
lymphoid-specific	NULL
components	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombinase	NULL
,	NULL
recombination-activating	NULL
genes	NULL
(	NULL
RAG	NULL
)	NULL
*-1	NULL
and	NULL
RAG-2	NULL
,	NULL
initiate	NULL
recombination	NULL
by	NULL
generating	NULL
double-strand	NULL
breaks	NULL
at	NULL
recombination	NULL
signal	NULL
sequences	NULL
(	NULL
RSSs	NULL
)	NULL
that	NULL
flank	NULL
all	NULL
Ag	NULL
receptor	NULL
gene	NULL
segments	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

RAG-mediated	NULL
cleavage	NULL
produces	NULL
two	NULL
distinct	NULL
intermediates	NULL
,	NULL
termed	NULL
coding	NULL
ends	NULL
(	NULL
CEs	NULL
)	NULL
and	NULL
signal	NULL
ends	NULL
(	NULL
SEs	NULL
)	NULL
,	NULL
which	NULL
are	NULL
differentially	NULL
processed	NULL
before	NULL
their	NULL
resolution	NULL
by	NULL
ubiquitous	NULL
DNA	NULL
repair	NULL
en-zymes	NULL
.	NULL

In	NULL
general	NULL
,	NULL
SEs	NULL
are	NULL
ligated	NULL
with	NULL
few	NULL
modifications	NULL
to	NULL
produce	NULL
flush	NULL
,	NULL
extrachromosomal	NULL
signal	NULL
joins	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
nucleotides	NULL
are	NULL
randomly	NULL
added	NULL
to	NULL
or	NULL
deleted	NULL
from	NULL
CEs	NULL
to	NULL
further	NULL
diversify	NULL
chromosomal	NULL
coding	NULL
joins	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
action	NULL
of	NULL
a	NULL
common	NULL
recombinase	NULL
on	NULL
highly	NULL
conserved	NULL
RSSs	NULL
,	NULL
the	NULL
assembly	NULL
of	NULL
individual	NULL
Ag	NULL
receptor	NULL
genes	NULL
occurs	NULL
in	NULL
a	NULL
stage-	NULL
and	NULL
tissue-specific	NULL
manner	NULL
.	NULL

Prior	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
substrate	NULL
specificity	NULL
is	NULL
imposed	NULL
on	NULL
the	NULL
recombination	NULL
process	NULL
by	NULL
modulating	NULL
the	NULL
accessibility	NULL
of	NULL
gene	NULL
segment	NULL
clusters	NULL
within	NULL
Ig	NULL
and	NULL
TCR	NULL
loci	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

In	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
cases	NULL
,	NULL
recombinational	NULL
accessibility	NULL
of	NULL
a	NULL
given	NULL
gene	NULL
segment	NULL
correlates	NULL
temporally	NULL
with	NULL
its	NULL
transcriptional	NULL
status	NULL
in	NULL
vivo	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

Consistent	NULL
P	NULL
recursor	NULL
lymphocytes	NULL
generate	NULL
functional	NULL
Ig	NULL
and	NULL
TCR	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
9	NULL
,	NULL
2001	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
18	NULL
,	NULL
2001	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
is	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
AI36944	NULL
and	NULL
AIO1412	NULL
(	NULL
to	NULL
E.M.O	NULL
.	NULL
)	NULL

and	NULL
a	NULL
National	NULL
Cancer	NULL
Institute	NULL
predoctoral	NULL
training	NULL
grant	NULL
(	NULL
to	NULL
H.H.B	NULL
.	NULL
)	NULL

.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Eugene	NULL
M.	NULL
Oltz	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
A4203	NULL
Medical	NULL
Center	NULL
North	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232-2363	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
oltzem	NULL
@	NULL
ctrvax.vanderbilt.edu	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
RAG	NULL
,	NULL
recombination-activating	NULL
gene	NULL
;	NULL
RSS	NULL
,	NULL
recombination	NULL
signal	NULL
sequence	NULL
;	NULL
CB	NULL
,	NULL
coding	NULL
end	NULL
;	NULL
SE	NULL
,	NULL
signal	NULL
end	NULL
;	NULL
iBx	NULL
,	NULL
Ig	NULL
intronic	NULL
en-hancer	NULL
;	NULL
LM-PCR	NULL
,	NULL
ligation-mediated	NULL
PCR	NULL
;	NULL
ts	NULL
,	NULL
temperature	NULL
sensitive	NULL
.	NULL

Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
with	NULL
a	NULL
causal	NULL
relationship	NULL
between	NULL
these	NULL
two	NULL
processes	NULL
,	NULL
transcriptional	NULL
promoter	NULL
and	NULL
enhancer	NULL
activities	NULL
are	NULL
required	NULL
for	NULL
the	NULL
efficient	NULL
rearrangement	NULL
of	NULL
chromosomal	NULL
gene	NULL
segments	NULL
in	NULL
cis	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

In	NULL
precursor	NULL
lymphocytes	NULL
,	NULL
fluctuations	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
target	NULL
promoter/enhancer	NULL
elements	NULL
likely	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
developmental	NULL
control	NULL
of	NULL
Ig	NULL
and	NULL
TCR	NULL
locus	NULL
accessibility	NULL
(	NULL
5	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
precise	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
cis-acting	NULL
elements	NULL
regulate	NULL
accessibility	NULL
remain	NULL
elusive	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
studies	NULL
indicate	NULL
that	NULL
directed	NULL
alterations	NULL
in	NULL
the	NULL
chromatin	NULL
associated	NULL
with	NULL
gene	NULL
segment	NULL
clusters	NULL
act	NULL
to	NULL
relieve	NULL
nucleo-some-mediated	NULL
repression	NULL
of	NULL
RSS	NULL
cleavage	NULL
by	NULL
the	NULL
RAG	NULL
proteins	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
B	NULL
lymphocyte	NULL
lineage	NULL
,	NULL
pro-B	NULL
cells	NULL
must	NULL
first	NULL
rearrange	NULL
a	NULL
functional	NULL
IgH	NULL
gene	NULL
before	NULL
recombination	NULL
of	NULL
the	NULL
Igx	NULL
locus	NULL
at	NULL
the	NULL
pre-B	NULL
cell	NULL
stage	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
pre-B	NULL
cell	NULL
models	NULL
,	NULL
the	NULL
onset	NULL
of	NULL
Jr	NULL
germline	NULL
transcription	NULL
and	NULL
VJx	NULL
rearrangement	NULL
requires	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
12	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
a	NULL
consensus	NULL
site	NULL
in	NULL
the	NULL
Ig	NULL
intronic	NULL
enhancer	NULL
(	NULL
iEx	NULL
)	NULL
.	NULL

Individual	NULL
pre-B	NULL
clones	NULL
that	NULL
fail	NULL
to	NULL
generate	NULL
an	NULL
in-frame	NULL
coding	NULL
join	NULL
subsequently	NULL
initiate	NULL
rearrangement	NULL
of	NULL
the	NULL
second	NULL
L	NULL
chain	NULL
locus	NULL
,	NULL
IgA	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Relative	NULL
to	NULL
Igx	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
transcription	NULL
factors	NULL
and	NULL
DNA	NULL
elements	NULL
that	NULL
regulate	NULL
recombination	NULL
of	NULL
IgA	NULL
gene	NULL
segments	NULL
.	NULL

Two	NULL
nearly	NULL
identical	NULL
IgA	NULL
enhancers	NULL
(	NULL
EA3-1	NULL
and	NULL
EA2-4	NULL
)	NULL
,	NULL
which	NULL
are	NULL
active	NULL
in	NULL
mature	NULL
B	NULL
and	NULL
plasma	NULL
cells	NULL
,	NULL
require	NULL
binding	NULL
by	NULL
the	NULL
PU.1/IFN	NULL
regulatory	NULL
factor-4	NULL
transcription	NULL
factor	NULL
complex	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
EA3-1	NULL
and	NULL
EA2-4	NULL
function	NULL
in	NULL
an	NULL
NF-	NULL
«	NULL
B-independent	NULL
manner	NULL
in	NULL
these	NULL
late-stage	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

During	NULL
the	NULL
course	NULL
of	NULL
our	NULL
studies	NULL
on	NULL
Ig	NULL
regulation	NULL
(	NULL
12	NULL
)	NULL
,	NULL
we	NULL
discovered	NULL
that	NULL
cells	NULL
defective	NULL
for	NULL
NF-KB	NULL
signaling	NULL
also	NULL
were	NULL
affected	NULL
at	NULL
the	NULL
IgA	NULL
locus	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
initial	NULL
observation	NULL
,	NULL
we	NULL
now	NULL
demonstrate	NULL
that	NULL
the	NULL
NF-KB	NULL
signaling	NULL
pathway	NULL
is	NULL
required	NULL
to	NULL
induce	NULL
germline	NULL
transcription	NULL
and	NULL
recombination	NULL
of	NULL
all	NULL
murine	NULL
VA	NULL
and	NULL
JA	NULL
gene	NULL
segments	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activities	NULL
of	NULL
known	NULL
IgA	NULL
regulatory	NULL
elements	NULL
are	NULL
unaffected	NULL
in	NULL
NF-	NULL
«	NULL
B-arrested	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
highlight	NULL
a	NULL
novel	NULL
mechanism	NULL
by	NULL
which	NULL
NF-	NULL
«	NULL
B	NULL
acts	NULL
as	NULL
a	NULL
global	NULL
regulator	NULL
of	NULL
Ig	NULL
L	NULL
chain	NULL
(	NULL
IgL	NULL
)	NULL
gene	NULL
assembly	NULL
in	NULL
precursor	NULL
B	NULL
cells	NULL
.	NULL

0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
lines	NULL
and	NULL
culture	NULL
The	NULL
103/BCL-2/4	NULL
pre-B	NULL
cell	NULL
line	NULL
is	NULL
conditionally	NULL
transformed	NULL
with	NULL
a	NULL
temperature-sensitive	NULL
(	NULL
ts	NULL
)	NULL
mutant	NULL
of	NULL
the	NULL
v-ab/	NULL
oncogene	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Stable	NULL
transfectants	NULL
of	NULL
ts-abl	NULL
expressing	NULL
a	NULL
dominant	NULL
inhibitor	NULL
of	NULL
NF-KB	NULL
,	NULL
termed	NULL
IxBAN	NULL
(	NULL
AN.1	NULL
,	NULL
AN.7	NULL
)	NULL
,	NULL
and	NULL
a	NULL
control	NULL
line	NULL
expressing	NULL
the	NULL
histidinol	NULL
resistance	NULL
gene	NULL
(	NULL
WT.24	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
routinely	NULL
propagated	NULL
at	NULL
34°C	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
50	NULL
uM	NULL
2-ME	NULL
,	NULL
and	NULL
0.01	NULL
%	NULL
penicillin-streptomycin	NULL
.	NULL

Inactivation	NULL
of	NULL
v-abl	NULL
was	NULL
achieved	NULL
by	NULL
incubation	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
(	NULL
38.5°C	NULL
)	NULL
for	NULL
either	NULL
24	NULL
or	NULL
48	NULL
h.	NULL
DNA	NULL
PCR	NULL
Relative	NULL
levels	NULL
of	NULL
V	NULL
«	NULL
Jr	NULL
and	NULL
VAJA	NULL
coding	NULL
joins	NULL
and	NULL
total	NULL
DNA	NULL
content	NULL
(	NULL
CA	NULL
)	NULL
were	NULL
assessed	NULL
by	NULL
semiquantitative	NULL
PCR	NULL
in	NULL
25-pl	NULL
reactions	NULL
containing	NULL
200	NULL
ng	NULL
genomic	NULL
DNA	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
1	NULL
pg/ml	NULL
BSA	NULL
,	NULL
200	NULL
M	NULL
dNTPs	NULL
,	NULL
Taq	NULL
polymerase	NULL
(	NULL
1	NULL
U	NULL
)	NULL
,	NULL
and	NULL
25	NULL
ng	NULL
of	NULL
each	NULL
primer	NULL
.	NULL

Amplifications	NULL
were	NULL
performed	NULL
as	NULL
follows	NULL
:	NULL
94°C	NULL
(	NULL
1	NULL
min	NULL
)	NULL
,	NULL
60°C	NULL
(	NULL
CA	NULL
)	NULL
or	NULL
52°C	NULL
(	NULL
VkJr	NULL
,	NULL
VAJA	NULL
)	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
(	NULL
1.5	NULL
min	NULL
)	NULL
for	NULL
either	NULL
24	NULL
(	NULL
CA	NULL
)	NULL
or	NULL
28	NULL
cycles	NULL
(	NULL
VkJx	NULL
,	NULL
VAJA	NULL
)	NULL
.	NULL

All	NULL
PCR	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
2	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
ZetaProbe	NULL
membranes	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
hybridization	NULL
with	NULL
the	NULL
appropriate	NULL
radiolabeled	NULL
probes	NULL
.	NULL

For	NULL
VA	NULL
and	NULL
JA	NULL
SEs	NULL
,	NULL
2.5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
the	NULL
permissive	NULL
or	NULL
nonpermissive	NULL
temperature	NULL
for	NULL
24	NULL
or	NULL
48	NULL
h.	NULL
Linker-ligated	NULL
DNA	NULL
plugs	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

SE	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
3	NULL
pl	NULL
of	NULL
molten	NULL
plugs	NULL
(	NULL
95°C	NULL
,	NULL
10	NULL
min	NULL
)	NULL
in	NULL
reaction	NULL
mixtures	NULL
as	NULL
described	NULL
for	NULL
the	NULL
coding	NULL
joins	NULL
assays	NULL
,	NULL
except	NULL
that	NULL
reactions	NULL
were	NULL
incubated	NULL
at	NULL
72°C	NULL
(	NULL
5	NULL
min	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
Taq	NULL
polymerase	NULL
(	NULL
1	NULL
U	NULL
)	NULL
.	NULL

The	NULL
12-cycle	NULL
amplifications	NULL
consisted	NULL
of	NULL
1	NULL
min	NULL
at	NULL
92°C	NULL
,	NULL
1	NULL
min	NULL
at	NULL
52°C	NULL
,	NULL
and	NULL
1.5	NULL
min	NULL
at	NULL
72°C	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
the	NULL
primary	NULL
PCR	NULL
(	NULL
2	NULL
l	NULL
)	NULL
then	NULL
was	NULL
amplified	NULL
for	NULL
28	NULL
cycles	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
but	NULL
with	NULL
a	NULL
nested	NULL
primer	NULL
.	NULL

RT-PCR	NULL
analyses	NULL
Total	NULL
cellular	NULL
RNA	NULL
(	NULL
3	NULL
pg	NULL
)	NULL
was	NULL
treated	NULL
with	NULL
RNase-free	NULL
DNase	NULL
I	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
subjected	NULL
to	NULL
reverse	NULL
transcription	NULL
with	NULL
random	NULL
hexamer	NULL
primers	NULL
.	NULL

To	NULL
discount	NULL
genomic	NULL
DNA	NULL
contamination	NULL
,	NULL
all	NULL
PCR	NULL
assays	NULL
included	NULL
controls	NULL
lacking	NULL
reverse	NULL
transcriptase	NULL
.	NULL

Samples	NULL
were	NULL
normalized	NULL
for	NULL
cDNA	NULL
input	NULL
using	NULL
a	NULL
separate	NULL
PCR	NULL
specific	NULL
for	NULL
B-actin	NULL
cDNA	NULL
sequences	NULL
.	NULL

PCR	NULL
amplifications	NULL
were	NULL
performed	NULL
as	NULL
follows	NULL
:	NULL
94°C	NULL
(	NULL
1	NULL
min	NULL
)	NULL
,	NULL
58°C	NULL
(	NULL
B-actin	NULL
)	NULL
,	NULL
50°C	NULL
(	NULL
VA1	NULL
,	NULL
VA2	NULL
,	NULL
Vx	NULL
)	NULL
,	NULL
or	NULL
48°C	NULL
(	NULL
JA1	NULL
,	NULL
JA2/3	NULL
)	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
(	NULL
1.5	NULL
min	NULL
)	NULL
for	NULL
either	NULL
24	NULL
(	NULL
G-actin	NULL
)	NULL
or	NULL
28	NULL
cycles	NULL
(	NULL
IgL	NULL
germline	NULL
transcripts	NULL
)	NULL
.	NULL

PCR	NULL
primers	NULL
and	NULL
probes	NULL
Oligonucleotide	NULL
primers	NULL
for	NULL
PCR	NULL
and	NULL
Southern	NULL
blot	NULL
probes	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
VkJ	NULL
«	NULL
2	NULL
coding	NULL
joins	NULL
:	NULL
primers	NULL
Vx	NULL
(	NULL
S	NULL
)	NULL
(	NULL
GGCTGCAGSTTCAGTG	NULL
GAAGTGGGTC	NULL
)	NULL
and	NULL
3'Jx2	NULL
(	NULL
GTGAACAAGAGTTGAGAAGAC	NULL
)	NULL
,	NULL
probe	NULL
Jr2	NULL
cod	NULL
(	NULL
TTCGGAGGGGGGACCAAGCTGG	NULL
)	NULL
;	NULL
VAJA	NULL
coding	NULL
joins	NULL
:	NULL
primers	NULL
VAR1	NULL
(	NULL
ATGAATTCACTGGTCTAATAGGTGGTACCA	NULL
)	NULL
and	NULL
JAR1	NULL
(	NULL
TAGAATTCACTYACCTAGGACAG	NULL
)	NULL
,	NULL
probes	NULL
VAR	NULL
(	NULL
CTGTGCTCTAT	NULL
GGTACAGCACCC	NULL
)	NULL
,	NULL
VAICP	NULL
(	NULL
GGATGAGGCAATAT	NULL
)	NULL
,	NULL
VAZCP	NULL
(	NULL
GAT	NULL
GATGCAATGTAT	NULL
)	NULL
,	NULL
JAICP	NULL
(	NULL
TTGGTGTTCTGGTGG	NULL
)	NULL
,	NULL
JAZCP	NULL
(	NULL
TAT	NULL
GTTTTCGGCGGT	NULL
)	NULL
,	NULL
and	NULL
JA3CP	NULL
(	NULL
TTTATTTTCGGCAGT	NULL
)	NULL
;	NULL
CA	NULL
control	NULL
:	NULL
primers	NULL
5'CA	NULL
(	NULL
CAGAATTCACCTTCCYCTGARGAG	NULL
)	NULL
and	NULL
3'CA	NULL
(	NULL
GAGTCGACARACTCTTCTCCA	NULL
)	NULL
,	NULL
probe	NULL
CAP	NULL
(	NULL
TACGAGAACGA	NULL
CAGTCCCAG	NULL
)	NULL
;	NULL
VAI	NULL
SEs	NULL
:	NULL
primers	NULL
BW-1H	NULL
(	NULL
CCGGGAGATCTGAATTC	NULL
CAC	NULL
)	NULL
,	NULL
3'VA1-1	NULL
(	NULL
GGTTCTCTTCTCAATG	NULL
)	NULL
,	NULL
and	NULL
3'VA1-2	NULL
(	NULL
TATGTTGT	NULL
GCCAAGTTGG	NULL
)	NULL
,	NULL
probe	NULL
3'VAIP	NULL
(	NULL
AAGTGGTAGTTATGAGACTGT	NULL
)	NULL
;	NULL
VAZ	NULL
SEs	NULL
:	NULL
primers	NULL
BW-1H	NULL
,	NULL
3'VA2-1	NULL
(	NULL
GTTGATAAACAAAGCTTGTC	NULL
)	NULL
,	NULL
and	NULL
3'VAZ-2	NULL
(	NULL
ATCAAGGCATAATTATTATAC	NULL
)	NULL
,	NULL
probe	NULL
3'VAZP	NULL
(	NULL
AGAAGATGGTAGTGAGACTG	NULL
)	NULL
;	NULL
VA	NULL
SE	NULL
control	NULL
:	NULL
primers	NULL
VAR1	NULL
(	NULL
AT	NULL
GAATTCACTGGTCTAATAGGTGGTACCA	NULL
)	NULL
and	NULL
3'VA1-2	NULL
,	NULL
probe	NULL
VAP	NULL
(	NULL
GTGTAGATGGGGAAGTAGA	NULL
)	NULL
;	NULL
JA2/3	NULL
SEs	NULL
:	NULL
primers	NULL
BW-1H	NULL
,	NULL
5'JA2/3-1	NULL
(	NULL
TACCACCCACTKCWWS	NULL
)	NULL
,	NULL
and	NULL
5'JA2/3-2	NULL
(	NULL
AGGTCAYAGCTC	NULL
CACC	NULL
)	NULL
,	NULL
probes	NULL
JAZSE	NULL
(	NULL
ACCAGGTGCTGGCCCCATAGG	NULL
)	NULL
and	NULL
JA3SE	NULL
(	NULL
CCCAGGTGCTTGCCCCACAGG	NULL
)	NULL
;	NULL
JA2/3	NULL
SE	NULL
control	NULL
:	NULL
primers	NULL
JAR1	NULL
and	NULL
3'JA2/3-2	NULL
(	NULL
AGGTCAYAGCTCCACC	NULL
)	NULL
,	NULL
probe	NULL
JAZ/3P	NULL
(	NULL
GGTTGGGTTITY	NULL
AGTCA	NULL
)	NULL
;	NULL
VAl	NULL
RT-PCR	NULL
:	NULL
primers	NULL
VAB	NULL
(	NULL
CACTTATACTCTCTCTC	NULL
CTGG	NULL
)	NULL
and	NULL
VAR	NULL
,	NULL
probes	NULL
VAICP	NULL
or	NULL
VAZCP	NULL
;	NULL
Vx	NULL
RT-PCR	NULL
:	NULL
primers	NULL
VB	NULL
(	NULL
GACATTCAGCTGACCCAGTCTCCA	NULL
)	NULL
and	NULL
V	NULL
«	NULL
RT	NULL
(	NULL
GGCCCGGGTT	NULL
TWTGTTMWGRBYGTAKCACAGTG	NULL
)	NULL
,	NULL
probe	NULL
VR	NULL
(	NULL
GTYCCWGAYC	NULL
CACTGCCACTGAASC	NULL
)	NULL
;	NULL
JAl	NULL
RT-PCR	NULL
:	NULL
primers	NULL
5'JA1l-2	NULL
(	NULL
GATCIT	NULL
TCAGTGATGTA	NULL
)	NULL
and	NULL
JAR1	NULL
,	NULL
probe	NULL
JAICP	NULL
;	NULL
JAZ	NULL
RT-PCR	NULL
:	NULL
primers	NULL
3-2	NULL
and	NULL
JAR1	NULL
,	NULL
probe	NULL
JAZCP	NULL
;	NULL
B-actin	NULL
RT-PCR	NULL
:	NULL
primers	NULL
5°	NULL
B-actin	NULL
(	NULL
AGAGCTATGAGCTGCCTGACGGCC	NULL
)	NULL
and	NULL
3	NULL
'	NULL
B-actin	NULL
(	NULL
AGTAATCTC	NULL
CTTCTGCATCCTGTC	NULL
)	NULL
,	NULL
probe	NULL
450-bp	NULL
cDNA	NULL
amplification	NULL
product	NULL
of	NULL
the	NULL
5	NULL
'	NULL
B-actin	NULL
and	NULL
3	NULL
'	NULL
B-actin	NULL
primers	NULL
.	NULL

265	NULL
Reporter	NULL
gene	NULL
assays	NULL
The	NULL
ts-abl	NULL
clones	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells/transfection	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
0.8	NULL
ml	NULL
serum-free	NULL
medium	NULL
and	NULL
transfected	NULL
transiently	NULL
with	NULL
a	NULL
0.2-ml	NULL
mixture	NULL
containing	NULL
12.5	NULL
ul	NULL
of	NULL
Lipofectin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
luciferase	NULL
plasmid	NULL
(	NULL
2.5	NULL
pg	NULL
)	NULL
,	NULL
and	NULL
a	NULL
control	NULL
Renilla	NULL
plasmid	NULL
(	NULL
0.5	NULL
ug	NULL
,	NULL
pRL-TK	NULL
;	NULL
Promega	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
cultured	NULL
at	NULL
34°C	NULL
for	NULL
5	NULL
h	NULL
,	NULL
washed	NULL
in	NULL
serum-free	NULL
medium	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
complete	NULL
medium	NULL
.	NULL

Subsequently	NULL
,	NULL
one-third	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
the	NULL
permissive	NULL
temperature	NULL
,	NULL
and	NULL
the	NULL
remaining	NULL
two-thirds	NULL
were	NULL
incubated	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
for	NULL
22	NULL
h.	NULL
Firefly	NULL
and	NULL
Renilla	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
in	NULL
protein	NULL
extracts	NULL
(	NULL
25	NULL
ug	NULL
)	NULL
with	NULL
a	NULL
dual	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
pVA	NULL
and	NULL
pVAEA	NULL
constructs	NULL
contain	NULL
the	NULL
VA2	NULL
promoter	NULL
alone	NULL
(	NULL
14	NULL
)	NULL
or	NULL
together	NULL
with	NULL
EA2-4	NULL
(	NULL
14	NULL
)	NULL
in	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pGL2	NULL
basic	NULL
plasmid	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
6x	NULL
«	NULL
B	NULL
plasmid	NULL
contains	NULL
six	NULL
xB	NULL
binding	NULL
sites	NULL
located	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
in	NULL
pGL2-basic	NULL
plasmid	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Results	NULL
NF-KB	NULL
regulates	NULL
Ig	NULL
gene	NULL
rearrangement	NULL
To	NULL
investigate	NULL
the	NULL
transcriptional	NULL
mechanisms	NULL
that	NULL
control	NULL
IgL	NULL
gene	NULL
assembly	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
conditionally	NULL
transformed	NULL
pre-B	NULL
cell	NULL
model	NULL
that	NULL
closely	NULL
mimics	NULL
the	NULL
physiology	NULL
of	NULL
primary	NULL
pre-B	NULL
cells	NULL
.	NULL

Inactivation	NULL
of	NULL
the	NULL
temperature-sensitive	NULL
v-ab/	NULL
oncogene	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
ts-abl	NULL
cells	NULL
)	NULL
induces	NULL
levels	NULL
of	NULL
RAG	NULL
gene	NULL
expression	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
IgL	NULL
rearrangement	NULL
that	NULL
are	NULL
comparable	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
vivo	NULL
(	NULL
12	NULL
,	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

We	NULL
generated	NULL
transfectants	NULL
of	NULL
the	NULL
ts-abl	NULL
line	NULL
that	NULL
stably	NULL
express	NULL
a	NULL
mutant	NULL
form	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
inhibitory	NULL
protein	NULL
IxBa	NULL
,	NULL
termed	NULL
I	NULL
«	NULL
BAN	NULL
.	NULL

This	NULL
transdominant	NULL
inhibitor	NULL
is	NULL
resistant	NULL
to	NULL
signal-dependent	NULL
proteolysis	NULL
and	NULL
blocks	NULL
nuclear	NULL
translo-cation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
containing	NULL
the	NULL
transactivating	NULL
subunits	NULL
c-Rel	NULL
and	NULL
RelA	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
prior	NULL
studies	NULL
,	NULL
we	NULL
found	NULL
that	NULL
inhibition	NULL
of	NULL
the	NULL
NF-KB	NULL
signaling	NULL
pathway	NULL
in	NULL
ts-abl	NULL
cells	NULL
blocked	NULL
germline	NULL
Jx	NULL
transcription	NULL
and	NULL
VxJr	NULL
rearrangement	NULL
,	NULL
presumably	NULL
by	NULL
interfering	NULL
with	NULL
iEx	NULL
function	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
Ig	NULL
locus	NULL
,	NULL
which	NULL
contains	NULL
~100	NULL
Vk	NULL
gene	NULL
segments	NULL
that	NULL
randomly	NULL
rearrange	NULL
with	NULL
four	NULL
functional	NULL
Jx	NULL
elements	NULL
,	NULL
the	NULL
murine	NULL
IgA	NULL
locus	NULL
primarily	NULL
uses	NULL
two	NULL
V	NULL
gene	NULL
segments	NULL
,	NULL
VA1	NULL
and	NULL
VA2	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
cells	NULL
that	NULL
fail	NULL
to	NULL
express	NULL
functional	NULL
Igx	NULL
protein	NULL
,	NULL
VA	NULL
segments	NULL
rearrange	NULL
preferentially	NULL
to	NULL
their	NULL
most	NULL
proximal	NULL
set	NULL
of	NULL
JA-CA	NULL
clusters	NULL
(	NULL
refer	NULL
to	NULL
diagram	NULL
of	NULL
the	NULL
IgA	NULL
locus	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Prior	NULL
studies	NULL
had	NULL
shown	NULL
that	NULL
IgA	NULL
enhancers	NULL
lack	NULL
«	NULL
B	NULL
sites	NULL
and	NULL
function	NULL
in	NULL
plasma	NULL
cells	NULL
that	NULL
are	NULL
deficient	NULL
for	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
expected	NULL
that	NULL
levels	NULL
of	NULL
IgA	NULL
rearrangements	NULL
would	NULL
be	NULL
unaffected	NULL
in	NULL
ts-abl	NULL
cells	NULL
expressing	NULL
a	NULL
dominant	NULL
repressor	NULL
of	NULL
NF-KB	NULL
signaling	NULL
.	NULL

To	NULL
quantify	NULL
IgA	NULL
rearrangements	NULL
in	NULL
control	NULL
ts-abl	NULL
cells	NULL
(	NULL
103	NULL
and	NULL
WT.24	NULL
transfectant	NULL
lacking	NULL
IxBAN	NULL
)	NULL
and	NULL
two	NULL
IBAN	NULL
expressing	NULL
clones	NULL
(	NULL
AN.1	NULL
and	NULL
AN.7	NULL
)	NULL
,	NULL
we	NULL
used	NULL
a	NULL
set	NULL
of	NULL
degenerate	NULL
PCR	NULL
primers	NULL
that	NULL
amplify	NULL
all	NULL
VAJA	NULL
coding	NULL
joins	NULL
with	NULL
equal	NULL
efficiency	NULL
.	NULL

Surpris-ingly	NULL
,	NULL
inactivation	NULL
of	NULL
v-abl	NULL
in	NULL
control	NULL
cells	NULL
induced	NULL
levels	NULL
of	NULL
VAJA	NULL
rearrangement	NULL
at	NULL
48	NULL
h	NULL
that	NULL
were	NULL
at	NULL
least	NULL
5-	NULL
to	NULL
10-fold	NULL
greater	NULL
than	NULL
those	NULL
observed	NULL
for	NULL
NF-	NULL
«	NULL
B-defective	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
top	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Recombinase	NULL
activity	NULL
was	NULL
unaffected	NULL
in	NULL
IxBAN	NULL
clones	NULL
as	NULL
judged	NULL
by	NULL
RAG-1/2	NULL
expression	NULL
and	NULL
rearrangement	NULL
of	NULL
extrachromosomal	NULL
substrates	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Similar	NULL
decreases	NULL
in	NULL
VAJA	NULL
rearrangement	NULL
were	NULL
observed	NULL
when	NULL
cells	NULL
cultured	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
were	NULL
sorted	NULL
for	NULL
viability	NULL
before	NULL
DNA	NULL
extraction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IxBAN-expressing	NULL
cells	NULL
in	NULL
the	NULL
process	NULL
of	NULL
VJ	NULL
or	NULL
VAJA	NULL
recombination	NULL
are	NULL
not	NULL
subject	NULL
to	NULL
significant	NULL
negative	NULL
selection	NULL
during	NULL
the	NULL
48	NULL
h	NULL
of	NULL
v-abl	NULL
inactivation	NULL
.	NULL

The	NULL
murine	NULL
IgA	NULL
locus	NULL
is	NULL
organized	NULL
into	NULL
two	NULL
rearrangement	NULL
cassettes	NULL
that	NULL
each	NULL
contain	NULL
VA	NULL
and	NULL
JA	NULL
gene	NULL
segments	NULL
as	NULL
well	NULL
as	NULL
CA	NULL
coding	NULL
exons	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

As	NULL
such	NULL
,	NULL
we	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
IgA	NULL
locus	NULL
contains	NULL
distinct	NULL
domains	NULL
,	NULL
each	NULL
of	NULL
which	NULL
may	NULL
be	NULL
differentially	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
all	NULL
gene	NULL
segments	NULL
are	NULL
equally	NULL
impaired	NULL
by	NULL
c-Rel/RelA	NULL
corepression	NULL
,	NULL
we	NULL
probed	NULL
IgA	NULL
rearrangements	NULL
in	NULL
ts-abl	NULL
DNAs	NULL
with	NULL
oligonucleotides	NULL
specific	NULL
for	NULL
each	NULL
VA	NULL
or	NULL
JA	NULL
coding	NULL
region	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
IxBAN	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
266	NULL
NF-	NULL
«	NULL
B	NULL
REGULATES	NULL
IgA	NULL
REARRANGEMENT	NULL
A	NULL
IgA	NULL
-a=3	NULL
s	NULL
%	NULL
w	NULL
*	NULL
~	NULL
/	NULL
~	NULL
I	NULL
I	NULL
JA-CA2	NULL
-	NULL
JA-CM	NULL
VM	NULL
JA-CAr3	NULL
-	NULL
JA-CM	NULL
WW	NULL
B	NULL
C.	NULL
$	NULL
ANA	NULL
_	NULL
ANZ	NULL
O	NULL
103	NULL
,	NULL
s	NULL
,	NULL
>	NULL
ANA	NULL
_	NULL
ANZ	NULL
wT24	NULL
103	NULL
&	NULL
'	NULL
ao	NULL
oa®	NULL
``	NULL
aP	NULL
Q	NULL
“	NULL
a	NULL
>	NULL
“	NULL
g	NULL
,	NULL
“	NULL
at	NULL
«	NULL
®	NULL
'	NULL
I	NULL
T	NULL
s	NULL
&	NULL
y	NULL
&	NULL
y	NULL
&	NULL
¢	NULL
,	NULL
&	NULL
_	NULL
P	NULL
T	NULL
él	NULL
P	NULL
‘	NULL
T	NULL
‘	NULL
T	NULL
F	NULL
T	NULL
‘	NULL
\|	NULL
P	NULL
é	NULL
]	NULL
‘	NULL
\|	NULL
|	NULL
|	NULL
.Temp	NULL
emp	NULL
IP	NULL
I	NULL
I	NULL
IIa	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
lI3	NULL
I	NULL
I	NULL
d	NULL
I	NULL
#	NULL
“	NULL
N3	NULL
,	NULL
&	NULL
m	NULL
twig	NULL
wines	NULL
‘	NULL
b	NULL
``	NULL
.	NULL

“	NULL
‘	NULL
w	NULL
_	NULL
VXJX	NULL
V	NULL
)	NULL
\,1	NULL
F	NULL
cam	NULL
am	NULL
v2	NULL
m	NULL
m	NULL
p	NULL
--	NULL
om	NULL
ni-	NULL
»	NULL
aon	NULL
<	NULL
o	NULL
@	NULL
@	NULL
iniiipniin	NULL
«	NULL
.	NULL

-	NULL
Vicjic1	NULL
C	NULL
“	NULL
-	NULL
-	NULL
VrJr2	NULL
--	NULL
-dbiba	NULL
»	NULL
-	NULL
-	NULL
=-	NULL
C	NULL
)	NULL
Do	NULL
b	NULL
ob	NULL
dood	NULL
od	NULL
ob	NULL
d	NULL
ob	NULL
jb	NULL
od	NULL
god	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
C1	NULL
_	NULL
--	NULL
~	NULL
I	NULL
FIGURE	NULL
1	NULL
.	NULL

IxBAN	NULL
inhibits	NULL
V	NULL
«	NULL
Jr	NULL
and	NULL
VAJA	NULL
rearrangement	NULL
.	NULL

A	NULL
,	NULL
Schematic	NULL
structure	NULL
of	NULL
the	NULL
murine	NULL
IgA	NULL
locus	NULL
.	NULL

Boxes	NULL
represent	NULL
coding	NULL
sequences	NULL
,	NULL
triangles	NULL
depict	NULL
RSSs	NULL
,	NULL
and	NULL
dashed	NULL
lines	NULL
indicate	NULL
the	NULL
predominant	NULL
VA	NULL
to	NULL
JA	NULL
rearrangement	NULL
events	NULL
observed	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
(	NULL
JA4	NULL
is	NULL
a	NULL
pseudogene	NULL
segment	NULL
lacking	NULL
a	NULL
consensus	NULL
RS	NULL
and	NULL
the	NULL
VAx	NULL
gene	NULL
segment	NULL
rarely	NULL
rearranges	NULL
)	NULL
.	NULL

B	NULL
,	NULL
PCR	NULL
analyses	NULL
of	NULL
VJ	NULL
(	NULL
middle	NULL
)	NULL
and	NULL
VAJA	NULL
coding	NULL
joins	NULL
(	NULL
top	NULL
)	NULL
.	NULL

Genomic	NULL
DNAs	NULL
from	NULL
the	NULL
103-BCL-2/4	NULL
pre-B	NULL
cell	NULL
line	NULL
(	NULL
103	NULL
)	NULL
,	NULL
transfectants	NULL
expressing	NULL
IBAN	NULL
(	NULL
AN.1	NULL
and	NULL
AN.7	NULL
)	NULL
,	NULL
or	NULL
a	NULL
control	NULL
transfectant	NULL
lacking	NULL
IBAN	NULL
(	NULL
WT.24	NULL
)	NULL
were	NULL
cultured	NULL
at	NULL
permissive	NULL
(	NULL
P	NULL
)	NULL
or	NULL
nonpermissive	NULL
(	NULL
N	NULL
)	NULL
temperatures	NULL
for	NULL
24	NULL
(	NULL
N24	NULL
)	NULL
or	NULL
48	NULL
h	NULL
(	NULL
N48	NULL
)	NULL
.	NULL

Rearrangement	NULL
levels	NULL
were	NULL
analyzed	NULL
with	NULL
degenerate	NULL
PCR	NULL
primers	NULL
that	NULL
recognize	NULL
all	NULL
V	NULL
or	NULL
J	NULL
gene	NULL
segments	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
linearity	NULL
of	NULL
each	NULL
PCR	NULL
assay	NULL
was	NULL
confirmed	NULL
with	NULL
serial	NULL
dilutions	NULL
of	NULL
the	NULL
103/N48	NULL
sample	NULL
(	NULL
lanes	NULL
12-14	NULL
)	NULL
,	NULL
and	NULL
control	NULL
reactions	NULL
were	NULL
performed	NULL
without	NULL
input	NULL
genomic	NULL
DNA	NULL
(	NULL
¢	NULL
)	NULL
.	NULL

A	NULL
PCR	NULL
assay	NULL
specific	NULL
for	NULL
the	NULL
CA	NULL
coding	NULL
exon	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
relative	NULL
amounts	NULL
of	NULL
input	NULL
DNA	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

C	NULL
,	NULL
Genomic	NULL
DNA	NULL
samples	NULL
were	NULL
amplified	NULL
as	NULL
in	NULL
B	NULL
.	NULL

Resultant	NULL
PCR	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
with	NULL
oligonucleotide	NULL
probes	NULL
specific	NULL
for	NULL
VA1	NULL
or	NULL
VAZ	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
probes	NULL
was	NULL
verified	NULL
with	NULL
DNA	NULL
samples	NULL
from	NULL
sequenced	NULL
VAIJA1	NULL
(	NULL
VA1	NULL
)	NULL
or	NULL
VA2ZJAZ	NULL
(	NULL
VA2	NULL
)	NULL
coding	NULL
joins	NULL
(	NULL
right	NULL
)	NULL
.	NULL

clones	NULL
exhibited	NULL
a	NULL
5-	NULL
to	NULL
10-fold	NULL
reduction	NULL
in	NULL
coding	NULL
joins	NULL
that	NULL
use	NULL
c-Rel	NULL
and	NULL
RelA	NULL
are	NULL
required	NULL
for	NULL
efficient	NULL
generation	NULL
of	NULL
VA	NULL
and	NULL
either	NULL
VA1	NULL
or	NULL
VAZ	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
JA1l-	NULL
,	NULL
JA2-	NULL
,	NULL
JA	NULL
SEs	NULL
and	NULL
JA3-specific	NULL
probes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
published	NULL
data	NULL
(	NULL
12	NULL
)	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
IxBAN	NULL
acts	NULL
as	NULL
a	NULL
global	NULL
repressor	NULL
of	NULL
both	NULL
VJ	NULL
and	NULL
VAJA	NULL
rearrangement	NULL
in	NULL
ts-abl	NULL
pre-B	NULL
cells	NULL
.	NULL

The	NULL
repressive	NULL
effects	NULL
of	NULL
IxBAN	NULL
on	NULL
VAJA	NULL
rearrangement	NULL
in	NULL
pre-B	NULL
cells	NULL
might	NULL
occur	NULL
at	NULL
two	NULL
distinct	NULL
levels-accessibility	NULL
of	NULL
IgA	NULL
gene	NULL
segments	NULL
or	NULL
efficient	NULL
resolution	NULL
of	NULL
VA	NULL
and	NULL
JA	NULL
CEs	NULL
by	NULL
DNA	NULL
repair	NULL
A	NULL
B	NULL
C	NULL
AN.1	NULL
_	NULL
_AN.Z	NULL
,	NULL
WT.24	NULL
,	NULL
_103	NULL
&	NULL
o	NULL
8	NULL
_	NULL
AN.1___AN.Z	NULL
-	NULL
WT.24	NULL
103	NULL
&	NULL
P	NULL
&	NULL
péfypému+§p	NULL
&	NULL
e§pxﬂ	NULL
’	NULL
é§	NULL
Temp	NULL
p	NULL
&	NULL
e§p¥	NULL
”	NULL
é§p	NULL
&	NULL
e§p	NULL
&	NULL
x	NULL
&	NULL
Temp	NULL
I	NULL
I	NULL
1-4	NULL
I	NULL
Lod	NULL
Ol	NULL
U	NULL
h	NULL
I	NULL
I-	NULL
d	NULL
I	NULL
I	NULL
Io	NULL
d	NULL
U	NULL
I	NULL
I	NULL
L-	NULL
d	NULL
«	NULL
m	NULL
<	NULL
gp	NULL
UW	NULL
Who	NULL
--	NULL
-V	NULL
)	NULL
i	NULL
SE	NULL
<	NULL
n	NULL
.	NULL

.—	NULL
-Vi2	NULL
SE	NULL
ws	NULL
«	NULL
--	NULL
-	NULL
#	NULL
B	NULL
-	NULL
We	NULL
-M	NULL
Ww	NULL
se	NULL
agam	NULL
«	NULL
-	NULL
CTRL	NULL
«	NULL
quan	NULL
tn	NULL
»	NULL
-	NULL
©	NULL
h	NULL
Dod	NULL
1	NULL
od	NULL
Pod	NULL
oo	NULL
bog	NULL
bod	NULL
1	NULL
)	NULL
|	NULL
I	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
13	NULL
1415	NULL
1	NULL
%	NULL
4	NULL
4	NULL
$	NULL
06	NULL
+	NULL
&	NULL
s	NULL
ad	NULL
ds	NULL
dads	NULL
FIGURE	NULL
2.	NULL
reduces	NULL
VA	NULL
and	NULL
JA	NULL
SE	NULL
formation	NULL
.	NULL

A	NULL
,	NULL
The	NULL
indicated	NULL
ts-abl	NULL
transfectants	NULL
were	NULL
cultured	NULL
at	NULL
the	NULL
permissive	NULL
(	NULL
P	NULL
)	NULL
or	NULL
nonpermissive	NULL
(	NULL
N	NULL
)	NULL
temperature	NULL
for	NULL
24	NULL
(	NULL
N24	NULL
)	NULL
or	NULL
48	NULL
h	NULL
(	NULL
N48	NULL
)	NULL
.	NULL

Agarose-embedded	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
VAl	NULL
(	NULL
top	NULL
)	NULL
or	NULL
VA2	NULL
(	NULL
middle	NULL
)	NULL
SEs	NULL
with	NULL
nested	NULL
LM-PCR	NULL
techniques	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
each	NULL
SE	NULL
(	NULL
right	NULL
)	NULL
was	NULL
verified	NULL
by	NULL
comigration	NULL
with	NULL
products	NULL
specifically	NULL
amplified	NULL
in	NULL
bone	NULL
marrow	NULL
DNA	NULL
samples	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
linearity	NULL
of	NULL
each	NULL
LM-PCR	NULL
assay	NULL
was	NULL
confirmed	NULL
with	NULL
serial	NULL
dilutions	NULL
of	NULL
the	NULL
103/N48	NULL
sample	NULL
(	NULL
lanes	NULL
13-15	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
input	NULL
DNA	NULL
were	NULL
assessed	NULL
with	NULL
primers	NULL
that	NULL
amplify	NULL
sequences	NULL
within	NULL
the	NULL
VAZ	NULL
coding	NULL
region	NULL
(	NULL
CTRL	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Samples	NULL
in	NULL
A	NULL
were	NULL
amplified	NULL
by	NULL
LM-PCR	NULL
methods	NULL
that	NULL
specifically	NULL
detect	NULL
JAZ	NULL
(	NULL
fop	NULL
)	NULL
or	NULL
JA3	NULL
SEs	NULL
(	NULL
middle	NULL
)	NULL
.	NULL

Control	NULL
assays	NULL
for	NULL
input	NULL
DNA	NULL
amplify	NULL
JAZ	NULL
coding	NULL
sequences	NULL
(	NULL
CTRL	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
AN.1	NULL
AN.Z	NULL
WT.24	NULL
103	NULL
A	NULL
»	NULL
267	NULL
1.0	NULL
E	NULL
C	NULL
z	NULL
0	NULL
0.8	NULL
0.6	NULL
0.4	NULL
0.2-	NULL
0	NULL
-	NULL
...	NULL
.	NULL

COP	NULL
__	NULL
op	NULL
cnc	NULL
ui	NULL
p	NULL
fr	NULL
E	NULL
OE	NULL
Oj	NULL
AN	NULL
AN	NULL
WT	NULL
WT	NULL
AN	NULL
AN	NULL
WT	NULL
WT	NULL
AN	NULL
AN	NULL
WT	NULL
WT	NULL
AN	NULL
AN	NULL
WT	NULL
WT	NULL
AN	NULL
AN	NULL
WT	NULL
WT	NULL
JM	NULL
JA2	NULL
VM	NULL
V2	NULL
Vr	NULL
FIGURE	NULL
3	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
regulates	NULL
IgA	NULL
germline	NULL
transcription	NULL
.	NULL

A	NULL
,	NULL
Total	NULL
RNA	NULL
from	NULL
the	NULL
indicated	NULL
ts-abl	NULL
transfectants	NULL
propagated	NULL
24	NULL
h	NULL
at	NULL
the	NULL
indicated	NULL
temperatures	NULL
were	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
assays	NULL
with	NULL
primer	NULL
combinations	NULL
that	NULL
amplify	NULL
germline	NULL
JA	NULL
gene	NULL
segments	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
blotted	NULL
and	NULL
probed	NULL
with	NULL
oligonucleotides	NULL
specific	NULL
for	NULL
JA1	NULL
(	NULL
fop	NULL
)	NULL
or	NULL
JAZ	NULL
coding	NULL
sequences	NULL
(	NULL
middle	NULL
)	NULL
.	NULL

Relative	NULL
levels	NULL
of	NULL
input	NULL
cDNA	NULL
were	NULL
measured	NULL
by	NULL
an	NULL
RT-PCR	NULL
assay	NULL
for	NULL
B-actin	NULL
transcripts	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

The	NULL
linearity	NULL
of	NULL
each	NULL
assay	NULL
was	NULL
demonstrated	NULL
by	NULL
serial	NULL
dilutions	NULL
of	NULL
the	NULL
103/N	NULL
cDNA	NULL
(	NULL
Zanes	NULL
9-11	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Quantitation	NULL
of	NULL
RT-PCR	NULL
assays	NULL
for	NULL
germline	NULL
IgL	NULL
transcripts	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
the	NULL
amount	NULL
of	NULL
signal	NULL
from	NULL
indicated	NULL
germline	NULL
transcription	NULL
assays	NULL
(	NULL
phosphor	NULL
imager	NULL
;	NULL
Fuji	NULL
)	NULL
normalized	NULL
for	NULL
levels	NULL
of	NULL
B-actin	NULL
signal	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

Data	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
shown	NULL
from	NULL
control	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
IxBAN-expressing	NULL
clones	NULL
(	NULL
AN	NULL
)	NULL
incubated	NULL
at	NULL
either	NULL
the	NULL
permissive	NULL
(	NULL
]	NULL
)	NULL
or	NULL
the	NULL
nonpermissive	NULL
(	NULL
@	NULL
@	NULL
)	NULL
temperature	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
maximum	NULL
normalized	NULL
signal	NULL
in	NULL
each	NULL
assay	NULL
was	NULL
standardized	NULL
to	NULL
the	NULL
value	NULL
of	NULL
1.0	NULL
in	NULL
each	NULL
data	NULL
set	NULL
.	NULL

complexes	NULL
(	NULL
20	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
IgA	NULL
accessibility	NULL
is	NULL
regulated	NULL
by	NULL
NF-KB	NULL
,	NULL
levels	NULL
of	NULL
RAG-mediated	NULL
cleavage	NULL
were	NULL
monitored	NULL
with	NULL
ligation-mediated	NULL
PCR	NULL
(	NULL
LM-PCR	NULL
)	NULL
assays	NULL
that	NULL
specifically	NULL
detect	NULL
VA	NULL
or	NULL
JA	NULL
SEs	NULL
(	NULL
17	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
SE	NULL
appearance	NULL
for	NULL
all	NULL
IgA	NULL
gene	NULL
segments	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
coding	NULL
joins	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
A	NULL
SEs	NULL
accumulated	NULL
only	NULL
after	NULL
24-48	NULL
h	NULL
of	NULL
culturing	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
(	NULL
Janes	NULL
7-12	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
I	NULL
<	NULL
BAN-expressing	NULL
clones	NULL
exhibited	NULL
a	NULL
5-	NULL
to	NULL
10-fold	NULL
reduction	NULL
in	NULL
all	NULL
VA	NULL
and	NULL
JA	NULL
SEs	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Our	NULL
prior	NULL
studies	NULL
of	NULL
extrachromosomal	NULL
substrates	NULL
showed	NULL
that	NULL
recombination	NULL
of	NULL
accessible	NULL
RSSs	NULL
is	NULL
unaffected	NULL
by	NULL
IxBAN	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
these	NULL
findings	NULL
strongly	NULL
suggest	NULL
that	NULL
NF-B	NULL
is	NULL
required	NULL
for	NULL
RAG-mediated	NULL
cleavage	NULL
of	NULL
IgA	NULL
gene	NULL
segments	NULL
,	NULL
the	NULL
initial	NULL
step	NULL
of	NULL
VAJA	NULL
rearrangement	NULL
.	NULL

IgA	NULL
germline	NULL
transcription	NULL
is	NULL
repressed	NULL
in	NULL
Rel-deficient	NULL
pre-B	NULL
cells	NULL
Current	NULL
evidence	NULL
suggests	NULL
that	NULL
Ag	NULL
receptor	NULL
loci	NULL
are	NULL
activated	NULL
for	NULL
rearrangement	NULL
via	NULL
the	NULL
binding	NULL
of	NULL
developmentally	NULL
regulated	NULL
transcription	NULL
factors	NULL
to	NULL
Ig	NULL
and	NULL
TCR	NULL
enhancers	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
functional	NULL
enhancers	NULL
direct	NULL
germline	NULL
transcription	NULL
of	NULL
linked	NULL
gene	NULL
segments	NULL
,	NULL
which	NULL
is	NULL
likely	NULL
required	NULL
for	NULL
their	NULL
accessibility	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
regulatory	NULL
model	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
previously	NULL
a	NULL
requirement	NULL
for	NULL
c-Rel/ReIA	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
Jx-C	NULL
«	NULL
germline	NULL
transcription	NULL
and	NULL
rearrangement	NULL
in	NULL
ts-abl	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
accessibility	NULL
mechanisms	NULL
at	NULL
the	NULL
IgA	NULL
locus	NULL
,	NULL
we	NULL
designed	NULL
a	NULL
series	NULL
of	NULL
semiquantitative	NULL
RT-PCR	NULL
assays	NULL
that	NULL
are	NULL
specific	NULL
for	NULL
transcripts	NULL
derived	NULL
from	NULL
unrearranged	NULL
IgA	NULL
gene	NULL
segments	NULL
.	NULL

Initially	NULL
,	NULL
total	NULL
cDNA	NULL
was	NULL
prepared	NULL
from	NULL
each	NULL
ts-abl	NULL
clone	NULL
cultured	NULL
at	NULL
the	NULL
permissive	NULL
and	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
268	NULL
nonpermissive	NULL
temperatures	NULL
.	NULL

Subsequent	NULL
to	NULL
PCR	NULL
amplification	NULL
,	NULL
germline	NULL
transcripts	NULL
were	NULL
detected	NULL
with	NULL
oligonucleotide	NULL
probes	NULL
specific	NULL
for	NULL
the	NULL
JA1	NULL
or	NULL
JAZ	NULL
gene	NULL
segments	NULL
,	NULL
which	NULL
reside	NULL
in	NULL
separate	NULL
IgA	NULL
cassettes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
levels	NULL
of	NULL
germline	NULL
JA	NULL
transcripts	NULL
were	NULL
significantly	NULL
reduced	NULL
in	NULL
IxBAN-expressing	NULL
pre-B	NULL
cells	NULL
cultured	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
.	NULL

Control	NULL
assays	NULL
for	NULL
B-actin	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
bottom	NULL
)	NULL
and	NULL
GAPDH	NULL
coding	NULL
sequences	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
revealed	NULL
a	NULL
general	NULL
diminution	NULL
in	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
most	NULL
transcripts	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
.	NULL

To	NULL
correct	NULL
for	NULL
this	NULL
global	NULL
effect	NULL
,	NULL
germline	NULL
transcription	NULL
data	NULL
were	NULL
quantified	NULL
(	NULL
phosphor	NULL
imager	NULL
;	NULL
Fuji	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
normalized	NULL
for	NULL
levels	NULL
of	NULL
B-actin	NULL
transcripts	NULL
present	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

Results	NULL
from	NULL
a	NULL
representative	NULL
set	NULL
of	NULL
experiments	NULL
for	NULL
each	NULL
VA	NULL
and	NULL
JA	NULL
assay	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

In	NULL
wild-type	NULL
pre-B	NULL
cells	NULL
,	NULL
all	NULL
VA	NULL
and	NULL
JA	NULL
germline	NULL
transcripts	NULL
were	NULL
induced	NULL
after	NULL
inactivation	NULL
of	NULL
the	NULL
v-abl	NULL
oncogene	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
there	NULL
was	NULL
a	NULL
consistent	NULL
reduction	NULL
in	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
germline	NULL
IgA	NULL
transcripts	NULL
measured	NULL
in	NULL
IxBAN	NULL
pre-B	NULL
clones	NULL
.	NULL

The	NULL
observed	NULL
reduction	NULL
in	NULL
IgA	NULL
transcripts	NULL
was	NULL
not	NULL
a	NULL
general	NULL
phenomenon	NULL
,	NULL
because	NULL
a	NULL
separate	NULL
assay	NULL
for	NULL
Vr	NULL
germline	NULL
mRNAs	NULL
revealed	NULL
no	NULL
significant	NULL
differences	NULL
between	NULL
the	NULL
control	NULL
and	NULL
IBAN	NULL
clones	NULL
at	NULL
either	NULL
temperature	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
qualitatively	NULL
consistent	NULL
with	NULL
those	NULL
obtained	NULL
for	NULL
VAJA	NULL
rearrangement	NULL
,	NULL
indicating	NULL
a	NULL
locus-wide	NULL
repression	NULL
of	NULL
IgA	NULL
accessibility	NULL
in	NULL
NF-	NULL
«	NULL
B-arrested	NULL
cells	NULL
.	NULL

IgA	NULL
promoter	NULL
and	NULL
enhancer	NULL
activities	NULL
are	NULL
unaffected	NULL
by	NULL
IxBAN	NULL
Prior	NULL
DNA	NULL
sequence	NULL
analyses	NULL
provide	NULL
no	NULL
evidence	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
NF-KB	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
known	NULL
IgA	NULL
enhancers	NULL
(	NULL
EA3-1	NULL
and	NULL
EA2-4	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
both	NULL
IgA	NULL
enhancers	NULL
are	NULL
fully	NULL
functional	NULL
in	NULL
a	NULL
plasma	NULL
cell	NULL
line	NULL
that	NULL
lacks	NULL
nuclear	NULL
NF-KB	NULL
(	NULL
14	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remained	NULL
possible	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
regulates	NULL
EA	NULL
function	NULL
via	NULL
an	NULL
indirect	NULL
mechanism	NULL
in	NULL
earlier	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
controls	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
Oct-2	NULL
,	NULL
a	NULL
B	NULL
lineage-specific	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
critical	NULL
sites	NULL
in	NULL
all	NULL
Ig	NULL
promoters	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
possibility	NULL
that	NULL
NF-KB	NULL
regulates	NULL
known	NULL
IgA	NULL
elements	NULL
in	NULL
ts-abl	NULL
cells	NULL
,	NULL
we	NULL
monitored	NULL
the	NULL
activity	NULL
of	NULL
EA2-4	NULL
and	NULL
the	NULL
VAZ	NULL
promoter	NULL
(	NULL
PVA	NULL
)	NULL
with	NULL
a	NULL
series	NULL
of	NULL
luciferase	NULL
reporter	NULL
genes	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
luciferase	NULL
expression	NULL
from	NULL
a	NULL
control	NULL
construct	NULL
driven	NULL
by	NULL
a	NULL
hexamer	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
was	NULL
severely	NULL
impaired	NULL
in	NULL
IBAN	NULL
clones	NULL
cultured	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
function	NULL
of	NULL
both	NULL
PVA	NULL
and	NULL
EA	NULL
was	NULL
similar	NULL
in	NULL
the	NULL
IBAN	NULL
and	NULL
control	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
prior	NULL
finding	NULL
that	NULL
EA	NULL
activity	NULL
is	NULL
NF-	NULL
«	NULL
B-independent	NULL
in	NULL
mature	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
our	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
IgA	NULL
germline	NULL
transcription	NULL
and	NULL
recombinational	NULL
accessibility	NULL
are	NULL
regulated	NULL
independently	NULL
of	NULL
EA	NULL
function	NULL
in	NULL
pre-B	NULL
lymphocytes	NULL
.	NULL

Discussion	NULL
The	NULL
advent	NULL
of	NULL
pre-B	NULL
cells	NULL
harboring	NULL
a	NULL
conditional	NULL
mutant	NULL
of	NULL
the	NULL
v-abl	NULL
oncogene	NULL
has	NULL
provided	NULL
a	NULL
unique	NULL
opportunity	NULL
to	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
IgL	NULL
gene	NULL
transcription	NULL
and	NULL
rearrangement	NULL
while	NULL
bypassing	NULL
the	NULL
effects	NULL
of	NULL
cellular	NULL
transformation	NULL
.	NULL

When	NULL
cultured	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
,	NULL
these	NULL
ts-abl	NULL
cells	NULL
exhibit	NULL
levels	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
,	NULL
RAG	NULL
expression	NULL
,	NULL
and	NULL
VxJr	NULL
rearrangement	NULL
that	NULL
are	NULL
comparable	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
bone	NULL
marrow	NULL
pre-B	NULL
cells	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

By	NULL
using	NULL
a	NULL
dominant	NULL
mutant	NULL
of	NULL
IB	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
the	NULL
NF-KB	NULL
signaling	NULL
pathway	NULL
is	NULL
critically	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
VkJx	NULL
rearrangement	NULL
in	NULL
ts-abl	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Unlike	NULL
traditional	NULL
v-abl	NULL
pre-B	NULL
cells	NULL
,	NULL
the	NULL
ts-abl	NULL
lines	NULL
also	NULL
execute	NULL
high	NULL
levels	NULL
of	NULL
IgA	NULL
gene	NULL
assembly	NULL
(	NULL
23	NULL
)	NULL
.	NULL

This	NULL
unique	NULL
feature	NULL
has	NULL
allowed	NULL
us	NULL
to	NULL
explore	NULL
the	NULL
transcription	NULL
factor	NULL
requirements	NULL
for	NULL
efficient	NULL
VAJA	NULL
rearrangement	NULL
in	NULL
the	NULL
appropriate	NULL
developmental	NULL
context	NULL
.	NULL

Our	NULL
results	NULL
clearly	NULL
show	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
full	NULL
activation	NULL
of	NULL
IgA	NULL
germline	NULL
NF-	NULL
«	NULL
B	NULL
REGULATES	NULL
IgA	NULL
REARRANGEMENT	NULL
120000	NULL
D	NULL
AN	NULL
60000	NULL
l	NULL
6	NULL
~	NULL
L	NULL
#	NULL
40000	NULL
\-	NULL
An	NULL
2	NULL
z	NULL
30000	NULL
20000	NULL
10000	NULL
L____U	NULL
0	NULL
Lull	NULL
)	NULL
s	NULL
h	NULL
6x	NULL
xB	NULL
pVA	NULL
pVAEA	NULL
FIGURE	NULL
4	NULL
.	NULL

PVA	NULL
and	NULL
EA	NULL
activities	NULL
are	NULL
NF-	NULL
«	NULL
B-independent	NULL
in	NULL
ts-abl	NULL
pre-B	NULL
cells	NULL
.	NULL

Control	NULL
ts-abl	NULL
cells	NULL
(	NULL
WT	NULL
and	NULL
WT.24	NULL
,	NULL
MM	NULL
)	NULL
and	NULL
an	NULL
IxkBAN-ex-pressing	NULL
clone	NULL
(	NULL
AN.7	NULL
,	NULL
Q	NULL
]	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
either	NULL
a	NULL
hexamer	NULL
of	NULL
NF-B	NULL
binding	NULL
sites	NULL
(	NULL
6xxB	NULL
)	NULL
,	NULL
the	NULL
VA2Z	NULL
promoter	NULL
(	NULL
pVA	NULL
)	NULL
,	NULL
or	NULL
PVAZ	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
EAZ-4	NULL
enhancer	NULL
(	NULL
pVAEA	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
control	NULL
plasmid	NULL
encoding	NULL
Renilla	NULL
luciferase	NULL
and	NULL
were	NULL
maintained	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
for	NULL
22	NULL
h.	NULL
Protein	NULL
extracts	NULL
(	NULL
25	NULL
pug	NULL
)	NULL
were	NULL
assayed	NULL
for	NULL
firefly	NULL
and	NULL
Renilla	NULL
luciferase	NULL
activities	NULL
by	NULL
standard	NULL
methods	NULL
.	NULL

Results	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
reported	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
for	NULL
firefly	NULL
luciferase	NULL
and	NULL
are	NULL
normalized	NULL
for	NULL
Renilla	NULL
luciferase	NULL
activity	NULL
.	NULL

transcription	NULL
and	NULL
the	NULL
recombinational	NULL
accessibility	NULL
of	NULL
all	NULL
five	NULL
VA	NULL
and	NULL
JA	NULL
gene	NULL
segments	NULL
.	NULL

What	NULL
is	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
NF-KB	NULL
exerts	NULL
global	NULL
control	NULL
over	NULL
the	NULL
IgA	NULL
locus	NULL
in	NULL
pre-B	NULL
cells	NULL
?	NULL

Our	NULL
functional	NULL
data	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
core	NULL
VA	NULL
promoter	NULL
(	NULL
PVA	NULL
)	NULL
or	NULL
EA	NULL
elements	NULL
are	NULL
regulated	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
by	NULL
NF-KB	NULL
in	NULL
extrachromosomal	NULL
vectors	NULL
.	NULL

However	NULL
,	NULL
VA	NULL
germline	NULL
transcription	NULL
is	NULL
clearly	NULL
inhibited	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B-arrested	NULL
cells	NULL
,	NULL
whereas	NULL
Vx	NULL
germline	NULL
transcription	NULL
is	NULL
unaffected	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
endogenous	NULL
PVA	NULL
function	NULL
is	NULL
potentiated	NULL
in	NULL
a	NULL
chromosomal	NULL
context	NULL
by	NULL
unidentified	NULL
element	NULL
(	NULL
s	NULL
)	NULL
that	NULL
respond	NULL
to	NULL
the	NULL
NF-KB	NULL
signaling	NULL
pathway	NULL
in	NULL
ts-abl	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
control	NULL
the	NULL
activities	NULL
of	NULL
JA	NULL
germline	NULL
promoters	NULL
.	NULL

Emerging	NULL
studies	NULL
have	NULL
identified	NULL
the	NULL
presence	NULL
of	NULL
JACA	NULL
germline	NULL
transcripts	NULL
in	NULL
pre-B	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
,	NULL
but	NULL
the	NULL
location	NULL
and	NULL
functional	NULL
architecture	NULL
of	NULL
the	NULL
putative	NULL
JA	NULL
promoters	NULL
remain	NULL
unknown	NULL
.	NULL

Given	NULL
the	NULL
results	NULL
from	NULL
germline	NULL
transcription	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
these	NULL
promoter	NULL
elements	NULL
may	NULL
be	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
regulated	NULL
by	NULL
NF-KB	NULL
.	NULL

Resolution	NULL
of	NULL
these	NULL
important	NULL
issues	NULL
awaits	NULL
identification	NULL
of	NULL
the	NULL
precise	NULL
regulatory	NULL
sequences	NULL
within	NULL
the	NULL
IgA	NULL
locus	NULL
that	NULL
are	NULL
NE-	NULL
«	NULL
B-responsive	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
findings	NULL
support	NULL
a	NULL
model	NULL
for	NULL
IgA	NULL
activation	NULL
that	NULL
is	NULL
highly	NULL
reminiscent	NULL
of	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
Igx	NULL
activa-tion	NULL
.	NULL

Both	NULL
L	NULL
chain	NULL
loci	NULL
require	NULL
c-Rel	NULL
and	NULL
RelA	NULL
for	NULL
initiation	NULL
of	NULL
V-J	NULL
rearrangement	NULL
and	NULL
for	NULL
J-C	NULL
germline	NULL
transcription	NULL
.	NULL

During	NULL
Igx	NULL
ac-tivation	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
thought	NULL
to	NULL
function	NULL
primarily	NULL
via	NULL
binding	NULL
to	NULL
its	NULL
cognate	NULL
site	NULL
in	NULL
iEx	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Mouse	NULL
knockout	NULL
studies	NULL
indicate	NULL
that	NULL
iEx	NULL
is	NULL
critical	NULL
for	NULL
mediating	NULL
VJr	NULL
rearrangement	NULL
in	NULL
pre-B	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
distal	NULL
3'Ex	NULL
is	NULL
NF-	NULL
«	NULL
B-independent	NULL
and	NULL
plays	NULL
a	NULL
dominant	NULL
role	NULL
in	NULL
constitutive	NULL
expression	NULL
of	NULL
rearranged	NULL
Ig	NULL
genes	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
distal	NULL
IgA	NULL
enhancers	NULL
(	NULL
EA2-4	NULL
and	NULL
EA3-1	NULL
)	NULL
,	NULL
which	NULL
are	NULL
NF-	NULL
«	NULL
B-independent	NULL
,	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
the	NULL
major	NULL
regulators	NULL
of	NULL
IgA	NULL
expression	NULL
in	NULL
mature	NULL
B	NULL
cell	NULL
subsets	NULL
(	NULL
13	NULL
)	NULL
.	NULL

By	NULL
analogy	NULL
to	NULL
iEx	NULL
,	NULL
unidentified	NULL
NF-	NULL
«	NULL
B-dependent	NULL
elements	NULL
may	NULL
control	NULL
initial	NULL
locus	NULL
activation	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

In	NULL
both	NULL
the	NULL
ts-abl	NULL
system	NULL
and	NULL
a	NULL
second	NULL
pre-B	NULL
cell	NULL
model	NULL
(	NULL
24	NULL
)	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
IgA	NULL
germline	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
transcription	NULL
and	NULL
rearrangement	NULL
(	NULL
24-48	NULL
h	NULL
)	NULL
are	NULL
delayed	NULL
relative	NULL
to	NULL
Ig	NULL
(	NULL
12-24	NULL
h	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
pre-B	NULL
cells	NULL
induces	NULL
Igx	NULL
gene	NULL
assembly	NULL
by	NULL
its	NULL
direct	NULL
binding	NULL
to	NULL
iEx	NULL
,	NULL
these	NULL
kinetic	NULL
data	NULL
suggest	NULL
that	NULL
efficient	NULL
VAJA	NULL
rearrangement	NULL
may	NULL
require	NULL
the	NULL
prior	NULL
induction	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Oct-2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
indirect	NULL
regulation	NULL
of	NULL
a	NULL
novel	NULL
IgA	NULL
element	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
provide	NULL
an	NULL
attractive	NULL
explanation	NULL
for	NULL
the	NULL
temporal	NULL
order	NULL
of	NULL
L	NULL
chain	NULL
gene	NULL
assembly	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Michelle	NULL
Rohling	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
Ursula	NULL
Storb	NULL
(	NULL
Uni-versity	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
)	NULL
for	NULL
PVA/EA	NULL
fragments	NULL
,	NULL
Larry	NULL
Kerr	NULL
for	NULL
the	NULL
6xxB	NULL
construct	NULL
,	NULL
and	NULL
D.	NULL
Ballard	NULL
and	NULL
W.	NULL
Khan	NULL
(	NULL
Vanderbilt	NULL
University	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
)	NULL
for	NULL
valuable	NULL
comments	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Eastman	NULL
,	NULL
Q.	NULL
M.	NULL
,	NULL
T.	NULL
M.	NULL
Leu	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Schatz	NULL
.	NULL

1996	NULL
.	NULL

Initiation	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
in	NULL
vitro	NULL
obeying	NULL
the	NULL
12/23	NULL
rule	NULL
.	NULL

Nature	NULL
380:85	NULL
.	NULL

2.	NULL
van	NULL
Gent	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
D.	NULL
A.	NULL
Ramsden	NULL
,	NULL
and	NULL
M.	NULL
Gellert	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
RAG1	NULL
and	NULL
RAG2	NULL
proteins	NULL
establish	NULL
the	NULL
12/23	NULL
rule	NULL
in	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
.	NULL

Cell	NULL
85:107	NULL
.	NULL

3	NULL
.	NULL

Bogue	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
B.	NULL
Roth	NULL
.	NULL

1996	NULL
.	NULL

Mechanism	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:175	NULL
.	NULL

4	NULL
.	NULL

Stanhope-Baker	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
M.	NULL
Hudson	NULL
,	NULL
A.	NULL
L.	NULL
Shaffer	NULL
,	NULL
A.	NULL
Constantinescu	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Schlissel	NULL
.	NULL

1996	NULL
.	NULL

Cell	NULL
type-specific	NULL
chromatin	NULL
structure	NULL
determines	NULL
the	NULL
targeting	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombinase	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
85:887	NULL
.	NULL

5	NULL
.	NULL

Sleckman	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
J.	NULL
R.	NULL
Gorman	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1996	NULL
.	NULL

Accessibility	NULL
control	NULL
of	NULL
antigen-receptor	NULL
variable-region	NULL
gene	NULL
assembly	NULL
:	NULL
role	NULL
of	NULL
cis-acting	NULL
elements	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:459	NULL
.	NULL

6	NULL
.	NULL

Sikes	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
C.	NULL
C.	NULL
Suarez	NULL
,	NULL
and	NULL
E.	NULL
M.	NULL
Oltz	NULL
.	NULL

1999	NULL
.	NULL

Regulation	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
by	NULL
transcriptional	NULL
promoters	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19:2773	NULL
.	NULL

7	NULL
.	NULL

Whitehurst	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
S.	NULL
Chattopadhyay	NULL
,	NULL
and	NULL
J.	NULL
Chen	NULL
.	NULL

1999	NULL
.	NULL

Control	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombinational	NULL
accessibility	NULL
of	NULL
the	NULL
DB1	NULL
gene	NULL
segment	NULL
at	NULL
the	NULL
TCRB	NULL
locus	NULL
by	NULL
a	NULL
germline	NULL
promoter	NULL
.	NULL

Immunity	NULL
10:313	NULL
.	NULL

8	NULL
.	NULL

Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
H.	NULL
Singh	NULL
.	NULL

1999	NULL
.	NULL

Transcription	NULL
factors	NULL
in	NULL
lymphocyte	NULL
development	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
get	NULL
together	NULL
.	NULL

Cell	NULL
96:13	NULL
.	NULL

9	NULL
.	NULL

McMurry	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Krangel	NULL
.	NULL

2000	NULL
.	NULL

A	NULL
role	NULL
for	NULL
histone	NULL
acetylation	NULL
in	NULL
the	NULL
developmental	NULL
regulation	NULL
of	NULL
VDJ	NULL
recombination	NULL
.	NULL

Science	NULL
287:495	NULL
.	NULL

10	NULL
.	NULL

Kwon	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
B.	NULL
Morshead	NULL
,	NULL
J.	NULL
R.	NULL
Guyon	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Octtinger	NULL
.	NULL

2000	NULL
.	NULL

Histone	NULL
acetylation	NULL
and	NULL
hSWI/SNF	NULL
remodeling	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
stimulate	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
cleavage	NULL
of	NULL
nucleosomal	NULL
DNA	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
6:1037	NULL
.	NULL

11	NULL
.	NULL

Yamagami	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
ten	NULL
Boekel	NULL
,	NULL
C.	NULL
Schaniel	NULL
,	NULL
J.	NULL
Andersson	NULL
,	NULL
A.	NULL
Rolink	NULL
,	NULL
and	NULL
F.	NULL
Melchers	NULL
.	NULL

1999	NULL
.	NULL

Four	NULL
of	NULL
five	NULL
RAG-expressing	NULL
JC	NULL
«	NULL
~'~	NULL
small	NULL
pre-BII	NULL
cells	NULL
have	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

269	NULL
no	NULL
L	NULL
chain	NULL
gene	NULL
rearrangements	NULL
:	NULL
detection	NULL
by	NULL
high-efficiency	NULL
single	NULL
cell	NULL
PCR	NULL
.	NULL

Immunity	NULL
11:309	NULL
.	NULL

Scherer	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
H.	NULL
H.	NULL
Bendall	NULL
,	NULL
G.	NULL
M.	NULL
Zhang	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
E.	NULL
M.	NULL
Oltz	NULL
.	NULL

1996	NULL
.	NULL

Corepression	NULL
of	NULL
RelA	NULL
and	NULL
c-rel	NULL
inhibits	NULL
immunoglobulin	NULL
x	NULL
gene	NULL
transcription	NULL
and	NULL
rearrangement	NULL
in	NULL
precursor	NULL
B	NULL
lymphocytes	NULL
.	NULL

Immunity	NULL
5:563	NULL
.	NULL

Brass	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
A.	NULL
Q.	NULL
Zhu	NULL
,	NULL
and	NULL
H.	NULL
Singh	NULL
.	NULL

1999	NULL
.	NULL

Assembly	NULL
requirements	NULL
of	NULL
PU.1-Pip	NULL
(	NULL
IRF-4	NULL
)	NULL
activator	NULL
complexes	NULL
:	NULL
inhibiting	NULL
function	NULL
in	NULL
vivo	NULL
using	NULL
fused	NULL
dimers	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

18:977	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
M.	NULL
Rudin	NULL
,	NULL
D.	NULL
Haasch	NULL
,	NULL
D.	NULL
Chaplin	NULL
,	NULL
and	NULL
U.	NULL
Storb	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
novel	NULL
enhancer	NULL
in	NULL
the	NULL
immunoglobulin	NULL
A	NULL
locus	NULL
is	NULL
duplicated	NULL
and	NULL
functionally	NULL
independent	NULL
of	NULL
NF-kB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:978	NULL
.	NULL

Klug	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
S.	NULL
J.	NULL
Gerety	NULL
,	NULL
P.	NULL
C.	NULL
Shah	NULL
,	NULL
Y.	NULL
Y.	NULL
Chen	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
N.	NULL
Rosenberg	NULL
,	NULL
and	NULL
H.	NULL
Singh	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
v-abl	NULL
tyrosine	NULL
kinase	NULL
negatively	NULL
regulates	NULL
NF-B/Rel	NULL
factors	NULL
and	NULL
blocks	NULL
x	NULL
gene	NULL
transcription	NULL
in	NULL
pre-B	NULL
lymphocytes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:678	NULL
.	NULL

Chen	NULL
,	NULL
Y.	NULL
Y.	NULL
,	NULL
L.	NULL
C.	NULL
Wang	NULL
,	NULL
M.	NULL
S.	NULL
Huang	NULL
,	NULL
and	NULL
N.	NULL
Rosenberg	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
active	NULL
v-abl	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
blocks	NULL
immunoglobulin	NULL
light-chain	NULL
gene	NULL
rearrangement	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:688	NULL
.	NULL

Schlissel	NULL
,	NULL
M.	NULL
S.	NULL
1998	NULL
.	NULL

Structure	NULL
of	NULL
nonhairpin	NULL
coding-end	NULL
DNA	NULL
breaks	NULL
in	NULL
cells	NULL
undergoing	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:2029	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
L.	NULL
J.	NULL
Ransone	NULL
,	NULL
E.	NULL
Bengal	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1991.	NULL
c-rel	NULL
activates	NULL
but	NULL
v-rel	NULL
suppresses	NULL
transcription	NULL
from	NULL
B	NULL
sites	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:3715	NULL
.	NULL

Reilly	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
B.	NULL
Blomberg	NULL
,	NULL
T.	NULL
Imanishi-Kari	NULL
,	NULL
S.	NULL
Tonegawa	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
H.	NULL
N.	NULL
Eisen	NULL
.	NULL

1984	NULL
.	NULL

Restricted	NULL
association	NULL
of	NULL
V	NULL
and	NULL
J-C	NULL
gene	NULL
segments	NULL
for	NULL
mouse	NULL
A	NULL
chains	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:2484	NULL
.	NULL

Hempel	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
P.	NULL
Stanhope-Baker	NULL
,	NULL
N.	NULL
Mathieu	NULL
,	NULL
F.	NULL
Huang	NULL
,	NULL
M.	NULL
S.	NULL
Schlissel	NULL
,	NULL
and	NULL
P.	NULL
Ferrier	NULL
.	NULL

1998	NULL
.	NULL

Enhancer	NULL
control	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
at	NULL
the	NULL
TCRB	NULL
locus	NULL
:	NULL
differential	NULL
effects	NULL
on	NULL
DNA	NULL
cleavage	NULL
and	NULL
joining	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

12:2305	NULL
.	NULL

Lauzurica	NULL
,	NULL
P.	NULL
,	NULL
X.	NULL
P.	NULL
Zhong	NULL
,	NULL
M.	NULL
S.	NULL
Krangel	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Roberts	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
8	NULL
gene	NULL
rearrangement	NULL
by	NULL
CBF/PEBP2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1193	NULL
.	NULL

Bendall	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
C.	NULL
R.	NULL
Edson	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
E.	NULL
M.	NULL
Oltz	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factor	NULL
NF-KB	NULL
regulates	NULL
inducible	NULL
Oct-2	NULL
gene	NULL
expression	NULL
in	NULL
precursor	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:28826	NULL
.	NULL

Bailey	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
and	NULL
N.	NULL
Rosenberg	NULL
.	NULL

1997	NULL
.	NULL

Assessing	NULL
the	NULL
pathogenic	NULL
potential	NULL
of	NULL
the	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombinase	NULL
by	NULL
interlocus	NULL
immunoglobulin	NULL
light-chain	NULL
gene	NULL
rearrangement	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:887	NULL
.	NULL

Engel	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Rolink	NULL
,	NULL
and	NULL
S.	NULL
Weiss	NULL
.	NULL

1999	NULL
.	NULL

B	NULL
cells	NULL
are	NULL
programmed	NULL
to	NULL
activate	NULL
x	NULL
and	NULL
A	NULL
for	NULL
rearrangement	NULL
at	NULL
consecutive	NULL
developmental	NULL
stages	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

29:2167	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Inducibility	NULL
of	NULL
x	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-xB	NULL
by	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
.	NULL

Cell	NULL
47:921	NULL
.	NULL

Xu	NULL
,	NULL
Y.	NULL
,	NULL
L.	NULL
Davidson	NULL
,	NULL
F.	NULL
W.	NULL
Alt	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
Igx	NULL
light	NULL
chain	NULL
intronic	NULL
enhancer/matrix	NULL
attachment	NULL
region	NULL
impairs	NULL
but	NULL
does	NULL
not	NULL
abolish	NULL
rearrangement	NULL
.	NULL

Immunity	NULL
4:377	NULL
.	NULL

Gorman	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
N.	NULL
van	NULL
der	NULL
Stoep	NULL
,	NULL
R.	NULL
Monroe	NULL
,	NULL
M.	NULL
Cogne	NULL
,	NULL
L.	NULL
Davidson	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
Igx	NULL
enhancer	NULL
influences	NULL
the	NULL
ratio	NULL
of	NULL
Ig	NULL
versus	NULL
IgA	NULL
B	NULL
lymphocytes	NULL
.	NULL

Immunity	NULL
5:241	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

